Ethical and Legal Considerations in Breast Density Workshop
|
Thursday 23rd August 10 am – 4 pm 2018
Basil Hetzel Institute 37A Woodville Rd, Woodville, South Australia In this workshop, experts in breast density, breast cancer screening, health ethics and the law, together with patients and clinicians, will identify and explore ethical and legal issues associated with breast density notification. Attendance is free, however you need to register for catering purposes by Friday 17th August. To download the registration form, please click here. To view the program and list of presenters, please click here. |
Please direct queries to A/Prof Wendy Ingman Email: wendy.ingman@adelaide.edu.au Phone: (08) 8222 6141 |
Why Study Mammographic Density? Conference
October 10-11, 2018
Victorian Comprehensive Cancer Centre
Melbourne, Australia
Please join us this October 10th-11th in Melbourne, Australia at the new Victorian Comprehensive Cancer Centre to discuss recent developments in mammographic density research and how to translate what we know into clinical practice.
Please visit the conference website.
Register here and submit your Abstract here!
Deadline for Abstract submission: August 15th, 2018
Email here
Follow us on Facebook here
Victorian Comprehensive Cancer Centre
Melbourne, Australia
Please join us this October 10th-11th in Melbourne, Australia at the new Victorian Comprehensive Cancer Centre to discuss recent developments in mammographic density research and how to translate what we know into clinical practice.
Please visit the conference website.
Register here and submit your Abstract here!
Deadline for Abstract submission: August 15th, 2018
Email here
Follow us on Facebook here
|
|
|
Public Forum on Mammographic Density
Wednesday 22nd March 2017
6pm - 7:30pm
Institute of Health and Biomedical Innovation
60 Musk Ave, Kelvin Grove, Brisbane
Mammographic Density (MD) is the white area on a mammogram. Clear relationships have been shown between MD and risk and detection of breast cancer. Almost 8% of women aged between 40-74 years have extremely high breast density. When adjusted for age and body mass index, women in top MD quartiles have significantly increased risk of breast cancer in their lifetime, compared to the lowest quartile. Also, due to masking effects of MD, breast cancer screening is clearly less effective in women in the higher MD quartiles. These advances have significant implications for breast screening, and using mammograms as primary screening tools in population screening programs/private sector clinics.
Given increasing knowledge and understanding of health impacts of MD, this Public Lecture is timely and important. Confirmed speakers are leading mammographic density researcher Professor John Hopper and consumer advocate Gerda Evans.
This public lecture is free to attend. Places are limited so please RSVP early by emailing Dr Honor Hugo
Organised by the Australian Centre for Health Law Research & Institute of Health and Biomedical Innovation
6pm - 7:30pm
Institute of Health and Biomedical Innovation
60 Musk Ave, Kelvin Grove, Brisbane
Mammographic Density (MD) is the white area on a mammogram. Clear relationships have been shown between MD and risk and detection of breast cancer. Almost 8% of women aged between 40-74 years have extremely high breast density. When adjusted for age and body mass index, women in top MD quartiles have significantly increased risk of breast cancer in their lifetime, compared to the lowest quartile. Also, due to masking effects of MD, breast cancer screening is clearly less effective in women in the higher MD quartiles. These advances have significant implications for breast screening, and using mammograms as primary screening tools in population screening programs/private sector clinics.
Given increasing knowledge and understanding of health impacts of MD, this Public Lecture is timely and important. Confirmed speakers are leading mammographic density researcher Professor John Hopper and consumer advocate Gerda Evans.
This public lecture is free to attend. Places are limited so please RSVP early by emailing Dr Honor Hugo
Organised by the Australian Centre for Health Law Research & Institute of Health and Biomedical Innovation
Mammographic Density Symposium
Thursday 23rd March 2017
8:30am - 1:30pm
Institute of Health and Biomedical Innovation
60 Musk Ave, Kelvin Grove, Brisbane
Mammographic Density is the area of radiologically dense breast tissue on a radiogram; the white area. There is a growing body of medical knowledge about the incidence of mammographic density worldwide and its health implications for women. These advances have significant implications for breast screening, and using mammograms as primary screening tools in population screening programs/private sector clinics.
The opening address will be delivered by Dr Nancy Cappello, founder and Executive Director, Are You Dense (by skype from USA), whose advocacy inspired the first Mammographic Density law in Connecticut, USA in 2009. Similar legislation now exists in many other US states.
Symposium speakers (including mammographic density researchers; health law researchers; breast clinicians; radiologists; geneticists; and private and public breast screening providers) will discuss key areas of mammographic density research including pathobiology, density measurement, clinical responses, and select medico-legal issues associated with the communication of information about the health implications of mammographic density to Australian women.
This symposium is free to attend with morning tea and lunch to be provided.
Places are limited so please RSVP early by emailing Dr Honor Hugo
Organised by the Australian Centre for Health Law Research & Institute of Health and Biomedical Innovation
8:30am - 1:30pm
Institute of Health and Biomedical Innovation
60 Musk Ave, Kelvin Grove, Brisbane
Mammographic Density is the area of radiologically dense breast tissue on a radiogram; the white area. There is a growing body of medical knowledge about the incidence of mammographic density worldwide and its health implications for women. These advances have significant implications for breast screening, and using mammograms as primary screening tools in population screening programs/private sector clinics.
The opening address will be delivered by Dr Nancy Cappello, founder and Executive Director, Are You Dense (by skype from USA), whose advocacy inspired the first Mammographic Density law in Connecticut, USA in 2009. Similar legislation now exists in many other US states.
Symposium speakers (including mammographic density researchers; health law researchers; breast clinicians; radiologists; geneticists; and private and public breast screening providers) will discuss key areas of mammographic density research including pathobiology, density measurement, clinical responses, and select medico-legal issues associated with the communication of information about the health implications of mammographic density to Australian women.
This symposium is free to attend with morning tea and lunch to be provided.
Places are limited so please RSVP early by emailing Dr Honor Hugo
Organised by the Australian Centre for Health Law Research & Institute of Health and Biomedical Innovation
8th International Breast Density and
|
|